Baguia, Maria .
HRN: 24-66-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/08/2024
03/15/2024
IV
500mg
Q 8hrs
AGE; CAP-MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes